Myomo Inc (MYO)

Currency in USD
1.420
+0.110(+8.40%)
Closed·
1.370-0.050(-3.52%)
·
Advertisement
MYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2501.440
52 wk Range
0.6051.840
Key Statistics
Prev. Close
1.31
Open
1.29
Day's Range
1.25-1.44
52 wk Range
0.605-1.84
Volume
1.28M
Average Volume (3m)
833.5K
1-Year Change
-22.4044%
Book Value / Share
0.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.540
Upside
+219.72%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Myomo Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.540
(+219.72% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy1.10-22.54%2.00Maintain10/03/2026
Craig-Hallum
Buy2.00+40.85%8.00Maintain12/08/2025
Maxim Group
Buy4.00+181.69%8.00Maintain12/08/2025

Myomo Inc Earnings Call Summary for Q2/2026

  • Myomo Q2 revenue rose 21% YoY to $11.7M, beating estimates of $10.29M; net loss narrowed to $0.09/share vs. consensus of $0.10/share loss.
  • Gross margin expanded sharply to 72.1% from 62.7% YoY; adjusted EBITDA loss improved to $800K from $4M, signaling progress toward profitability.
  • Company raised full-year 2026 revenue guidance to $45M-$47M from prior $43M-$46M range; Q3 revenue expected at $11.5M-$12M.
  • Record 255 MyoPro unit orders placed in Q2, up 23% YoY; recurring patient referrals now represent 53% of revenue vs. 26% a year earlier.
  • Cash burn reduced to $1.9M from $8.9M YoY; management expects second-half 2026 cash burn below $2M as revenue growth outpaces expense increases.
Last Updated: 05/08/2026, 22:26
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
-0.09 / -0.10
Revenue / Forecast
11.7M / 10.29M
EPS Revisions
Last 90 days

Myomo (MYO) Income Statement & Profits

Compare MYO to Peers and Sector

Metrics to compare
MYO
Peers
Sector
Relationship
P/E Ratio
−3.8x−2.7x−0.4x
PEG Ratio
0.10−0.200.00
Price/Book
9.4x3.2x2.6x
Price / LTM Sales
1.3x2.9x3.1x
Upside (Analyst Target)
111.3%63.0%48.8%
Fair Value Upside
Unlock−5.7%5.7%Unlock

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.20M8.29%4.55M
Other Institutional Investors
22.19M57.42%31.51M
Public Companies & Retail Investors
13.25M34.29%18.81M
Total
38.64M100.00%54.87M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rosalind Advisors, Inc.9.96%3,847,2725,463
Rosalind Master Fund L.P.9.94%3,839,7725,452

People Also Watch

8.59
KRO
+4.37%
19.83
UPBD
+1.64%
3.660
IRD
-1.61%
0.2340
TPET
-2.50%
6.6700
GYRE
+4.22%

FAQ

What Is the Myomo (NYSE: MYO) Share Price Today?

The Myomo stock price today is 1.420 USD.

What Stock Exchange Does Myomo (MYO) Trade On?

Myomo is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Myomo?

The stock symbol (also called a 'ticker') for Myomo is "MYO."

What Is the Current Myomo Market Capitalisation?

As of today, Myomo (NYSE: MYO) market cap is 54.870M USD.

What Is Myomo's (MYO) Earnings Per Share (TTM)?

The Myomo EPS is currently -0.343 (Trailing Twelve Months).

When Is the Next Myomo Earnings Date?

Myomo's next earnings report will be released on 11/11/2026.

Is MYO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Myomo moving averages and other technical indicators, the daily buy/sell signal for MYO stock is Strong Buy.

How Many Times Has Myomo Stock Split?

Myomo has split 1 times. (See the MYO stock split history page for full effective split date and price information.)

How Many Employees Does Myomo Have?

Myomo has 195 employees, based on their latest Companies House report.

What is the current trading status of Myomo (NYSE: MYO)?

As of 09/08/2026, Myomo (MYO) is trading at a share price of 1.420 USD, with a previous close of 1.310 USD. The stock has fluctuated within a day range of 1.250 USD to 1.440 USD, while its 52-week range spans from 0.605 USD to 1.840 USD.

What Is Myomo (MYO) Price Target According to Analysts?

The average 12-month price target for Myomo is 4.540 USD, with a high estimate of 10 USD and a low estimate of 1.7 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +219.72% Upside potential.

What Is the MYO Premarket Price?

MYO's last pre-market stock price is 1.210 USD. The pre-market share volume is 20,370.000, and the stock has decreased by -0.100, or -7.630%.

What Is the MYO After Hours Price?

MYO's last after hours stock price is 1.370 USD, the stock has decreased by -0.050, or -3.520%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.